Adam Stops, Senior Director and Head of Product Management Devices at Stevanato Group, discusses the challenge of matching complex injectable formulations with delivery systems that meet developers’ and patients’ needs. In this video, he introduces the Alina and Deora pen injector platforms and explains what expanded manufacturing capabilities in Germany and the US mean for customers. He also shares what drug developers should consider when choosing a delivery system.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

I have read and understand the Privacy Notice*

Subscribe